DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.

Oncotarget · 2017 · PMC5352035 · PMID 27911866

Europe PMC DOI

hedged sentence

0.0720

closest p · 1.4× alpha

0.0720

boldest claim

The sentences

borderline significantp = 0.072so close (0.05 < p ≤ 0.1)

Classification by SAM40 was significantly associated with survival in the multivariate model for the samples in the Norway 27K study cohort ( p = 0.028), and borderline significant for the samples in the Norway450K study cohort ( p = 0.072).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.